Neox acquired by Emmes

January 25, 2021

Neox and Emmes will be a powerful combination. We look forward to continuing to serve our customers with the expanded resources of the Emmes organization, as well as helping Emmes support rapid patient enrollment in global clinical trials. Our regulatory contacts throughout Europe, who understand country-specific requirements, will be an asset in helping Emmes’ current and future biopharma customers with their global drug development strategic planning and clinical operations.” Dr. Marek.

Full press release here: 

https://cutt.ly/cj4QGkN

 

About Emmes

About Emmes Founded in 1977, Emmes is a global, full-service Clinical Research Organization dedicated to excellence in supporting the advancement of public health and biopharmaceutical innovation. The company’s clients include numerous agencies and institutes of the U.S. federal government and a wide range of biotechnology, pharmaceutical, and medical device companies throughout the world. To learn more about how our research is making a positive impact on human health, go to the Emmes website at www.emmes.com.



#neoxcro #emmes #clinicaltrials #patientenrollment #CRO #merger

NEOX acquired by Emmes